Molecular Cancer Therapeutics: Strategies for Drug Discovery and Development offers an up–to–date overview of the different phases of drug discovery and preclinical development of new experimental cancer principles. In tying together the diverse set of disciplines and methods involved in these pursuits, the text covers:
- Discovery and validation of drug targets
- Drug screening
- Animal models
- Preclinical testing
- Pharmacology issues
- Clinical concerns
- Intellectual property issues
Directed to a broad audience of students and professionals in academia and industry, Molecular Cancer Therapeutics provides a comprehensive summary of state–of–the–art strategies for identifying drug targets and developing lead inhibitors. With its coverage of target validation, drug screening, and pharmacokinetics, it is an invaluable reference for those working in oncology as well as the broad range of disciplines concerned with drug discovery and development.
Chapter 1. Introduction (G. Prendergast).
Chapter 2. Molecular Cancer Therapeutics: Will the Promise Be Fulfilled? (B. Teicher).
Chapter 3. Cancer Genetics and Drug Target Selection (G. Zhang & W. Kaelin).
Chapter 4. RNA Interference in Mammals: Journey to the Center of Human Disease (P. Paddison & G. Hannon).
Chapter 5. Applications and Issues for Tissue Arrays in Target and Drug Discovery (E. Jonasch, K. Do, C. Logothetis, & T. McDonnell).
Chapter 6. Protein Transduction Strategies for Target and Mechanism Validation (S. Ezhevsky & S. Dowdy).
Chapter 7. Drug Screening: Assay Development Issues (S. Carroll, J. Inglese, S. Mao, & D. Olson).
Chapter 8. Gene Microarray Technologies for Cancer Drug Discovery and Development (R. te Poele, P. Clarke, & P. Workman).
Chapter 9. Transgenic Mouse Models of Cancer (T. Bowen & A. Wynshaw–Boris).
Chapter 10. Transgenic versus Xenograft Mouse Models of Cancer: Utility and Issues (M. Liu, W. Bishop, Y. Wang, & P. Kirschmeier).
Chapter 11. Pharmacodynamic Assays in Cancer Drug Discovery: From Preclinical Validation to Clinical Trial Monitoring (R. Lobell, N. Kohl, & L. Sepp–Lorenzino).
Chapter 12. Pharmacokinetic and Toxicology Issues in Cancer Drug Discovery and Development (P. Benfield & B. Car).
Chapter 13. Clinical Development Issues (S. Averbuch, M. Wolf, B. El–Rayes, & P. LoRusso).
Chapter 14. Intellectual Property and Commercialization Issues in Drug Discovery (L. Malseed).
"...an excellent publication. I recommended it for libraries...those involved in cancer research...those who teach pharmacy and medical students about drugs used in the treatment of cancer." (The Annals of Pharmacotherapy, December 2004)
" provides an up–to–date overview of the different phases of drug discovery and preclinical development of experimental cancer principles. (Drug Discovery & Development, September 2004)
" a most informative book, discussing the important evolution in the field of cancer therapeutics " (American Journal of Therapeutics, July/August 2004)